Senior Leadership
Senior Leadership
批准号:
8533978
负责人:
Andrew S Kraft
金额:
$6.58万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
未结题
起止时间:
2012-04-01 至
关键词:
AddressAreaBasic ScienceBehavioral SciencesBioinformaticsBiometryCancer CenterCancer Center Support GrantCancer ControlCancer Control ResearchChargeClinicalClinical TrialsCollaborationsCommunity OutreachConsensusCounselingDevelopmentDisciplineDoctor of PhilosophyElementsEnsureEpidemiologyEvaluationFacultyFundingGap JunctionsGoalsIndividualInstitutionLeadLeadershipMedicalMolecular EpidemiologyPhysician ExecutivesPopulation SciencesPositioning AttributePublic HealthRecommendationResearchResearch PersonnelResource AllocationResource DevelopmentResource SharingResourcesSouth CarolinaStrategic PlanningTechniquesTimeTranslational ResearchUniversitiesVisionWorkauthoritybasebehavioral/social sciencecancer health disparitycancer preventionexperiencemeetingsmemberoutreachprogramsresearch and development
中文摘要
罗林斯癌症中心(HCC)由Andrew S. Kraft,MD(董事),
Anthony J. Alberg,PhD,MPH(癌症预防和控制副主任);丹尼尔J.费尔南德斯,
PhD(Associate Director of Translational Research); Marvella E.福特博士(癌症副主任
Disparities); Yusuf A. Hannun,MD(基础科学副主任); Anita L. Harrison,MPA(Associate
行政总监); Reed,MD(医学事务副总监); Steven A.
Rosenzweig博士(共享资源助理总监)和Melanie B。托马斯,医学博士(助理
临床研究总监)。这些经验丰富的个人被组织为高级领导
这个团队代表了这个矩阵式中心强大的功能联系。克拉夫特医生指控
团队成员在直接与各种
总部合同委员会各理事会和委员会制定优先事项、战略和资源分配。的
高级领导团队共同努力,确保中心愿景和目标的一致性;
中心的基础、翻译和临床要素之间的协同互动;主动计划
发展研究基础和资源的方法;有效地利用所有可用的
资源在MUSC和州和国家一级;参与社区外展;并监督所有
HCC的活动。
高级领导小组每月在总部合同委员会的各种活动范围内举行几次会议,
董事会/委员会/理事会会议,与董事一对一,每月一次作为正式执行官
理事会。他们根据这些互动向主任提供直接咨询意见和建议。所有
代表合同委员会作出决定的最终权力属于主任。
英文摘要
The Rollings Cancer Center (HCC) is directed by Andrew S. Kraft, MD (Director) with the assistance of
Anthony J. Alberg, PhD, MPH (Associate Director of Cancer Prevention & Control); Daniel J. Fernandes,
PhD (Associate Director of Translational Research); Marvella E. Ford, PhD (Associate Director of Cancer
Disparities); Yusuf A. Hannun, MD (Associate Director of Basic Sciences); Anita L. Harrison, MPA (Associate
Director of Administration); Carolyn E. Reed, MD (Associate Director of Medical Affairs); Steven A.
Rosenzweig, PhD (Assistant Director of Shared Resources); and Melanie B. Thomas, MD (Associate
Director of Clinical Investigations). These experienced individuals are organized as a Senior Leadership
team that represents the strong functional nexus of this matrix-based Center. Dr. Kraft has charged the
members of the team with employing consensus building techniques as they work directly with the various
HCC boards/councils and committees to formulate priorities, strategies and allocation of resources. The
Senior Leadership team works together to ensure consistency in the vision and goals of the Center; develop
synergistic interactions among the basic, translational, and clinical elements of the Center; plan proactive
approaches to the development of the research base and resources; effectively leverage all available
resources at MUSC and at the state and national levels; engage in community outreach; and oversee all
activities of the HCC.
The Senior Leadership team meets several times a month in the context of HCC's various
board/committee/council meetings, one-on-one with the Director, and once a month as a formal Executive
Council. They provide direct counsel and recommendations to the Director based on these interactions. All
final authority for decisions on behalf of the HCC resides with the Director.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of RNA Decapping and Degradation: A novel approach to prostate cancer therapy
-
批准号:10758110
-
项目类别:
-
资助金额:$39.72万
-
财政年份:2023
-
负责人:Andrew S Kraft
-
依托单位:
Pim 1 Protein Kinase in Regulating Stromal Cell Biology in Prostate Cancer
-
批准号:8855025
-
项目类别:
-
资助金额:$19.96万
-
财政年份:2015
-
负责人:Andrew S Kraft
-
依托单位:
MUSC/HCC Paul Calabresi Clinical Oncology Training Program Plan
-
批准号:8486908
-
项目类别:
-
资助金额:$16.38万
-
财政年份:2013
-
负责人:Andrew S Kraft
-
依托单位:
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
-
批准号:8735893
-
项目类别:
-
资助金额:$7.23万
-
财政年份:2013
-
负责人:Andrew S Kraft
-
依托单位:
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
-
批准号:8577635
-
项目类别:
-
资助金额:$31.02万
-
财政年份:2013
-
负责人:Andrew S Kraft
-
依托单位:
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
-
批准号:9039263
-
项目类别:
-
资助金额:$22.86万
-
财政年份:2013
-
负责人:Andrew S Kraft
-
依托单位:
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
-
批准号:9320825
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2013
-
负责人:Andrew S Kraft
-
依托单位:
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
-
批准号:8891388
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2013
-
负责人:Andrew S Kraft
-
依托单位:
LIPIDOMICS SHARED RESOURCE GROUP
-
批准号:8695810
-
项目类别:
-
资助金额:$8.14万
-
财政年份:2009
-
负责人:Andrew S Kraft
-
依托单位:
CELL AND MOLECULAR IMAGING
-
批准号:8695817
-
项目类别:
-
资助金额:$7.26万
-
财政年份:2009
-
负责人:Andrew S Kraft
-
依托单位:
BIOSTATISTICS SHARED RESOURCE GROUP
-
批准号:8695824
-
项目类别:
-
资助金额:$12.18万
-
财政年份:2009
-
负责人:Andrew S Kraft
-
依托单位:
Medical University of South Carolina - Cancer Center Support Grant
-
批准号:8923675
-
项目类别:
-
资助金额:$14.74万
-
财政年份:2009
-
负责人:Andrew S Kraft
-
依托单位:
Novel Inhibitors of Pim Protein Kinases
-
批准号:7743696
-
项目类别:
-
资助金额:$25.79万
-
财政年份:2009
-
负责人:Andrew S Kraft
-
依托单位:
Medical University of South Carolina - Cancer Center Support Grant
-
批准号:8322869
-
项目类别:
-
资助金额:$5.76万
-
财政年份:2009
-
负责人:Andrew S Kraft
-
依托单位:
Medical University of South Carolina - Cancer Center Support Grant
-
批准号:7795202
-
项目类别:
-
资助金额:$155.75万
-
财政年份:2009
-
负责人:Andrew S Kraft
-
依托单位:
BIOREPOSITORY & TISSUE ANALYSIS
-
批准号:8695842
-
项目类别:
-
资助金额:$6.65万
-
财政年份:2009
-
负责人:Andrew S Kraft
-
依托单位:
Medical University of South Carolina - Cancer Center Support Grant
-
批准号:7931536
-
项目类别:
-
资助金额:$254.87万
-
财政年份:2009
-
负责人:Andrew S Kraft
-
依托单位:
CANCER CONTROL
-
批准号:8695807
-
项目类别:
-
资助金额:$3.08万
-
财政年份:2009
-
负责人:Andrew S Kraft
-
依托单位:
CELL EVALUATION & THERAPY
-
批准号:8695829
-
项目类别:
-
资助金额:$6.47万
-
财政年份:2009
-
负责人:Andrew S Kraft
-
依托单位:
CANCER IMMUNOLOGY
-
批准号:8695803
-
项目类别:
-
资助金额:$3.08万
-
财政年份:2009
-
负责人:Andrew S Kraft
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: